{"id":8675,"date":"2021-08-08T17:30:16","date_gmt":"2021-08-09T00:30:16","guid":{"rendered":"https:\/\/www.telemedical.com\/wordpress\/?page_id=8675"},"modified":"2021-08-08T18:30:37","modified_gmt":"2021-08-09T01:30:37","slug":"references","status":"publish","type":"page","link":"https:\/\/www.telemedical.com\/wordpress\/covid-19-treatments\/references\/","title":{"rendered":"References"},"content":{"rendered":"\n<p> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1359644620300416#bib0475\">Treatments<\/a> <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.nature.com\/articles\/s41467-021-23328-0#MOESM3\">Drug repurposing screens identify chemical entities for the development of COVID-19 interventions<\/a><\/h3>\n\n\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/www.nature.com\/articles\/s41467-021-23328-0#auth-Malina_A_-Bakowski\">Malina A. Bakowski<\/a>,&nbsp;<\/li><li><a href=\"https:\/\/www.nature.com\/articles\/s41467-021-23328-0#auth-Nathan-Beutler\">Nathan Beutler<\/a>,&nbsp;<\/li><li><a href=\"https:\/\/www.nature.com\/articles\/s41467-021-23328-0#auth-Thomas_F_-Rogers\">Thomas F. Rogers<\/a>&nbsp;<\/li><\/ul>\n\n\n\n<p><a href=\"https:\/\/www.nature.com\/ncomms\"><em>Nature Communications<\/em><\/a>&nbsp;<strong>volume&nbsp;12<\/strong>, Article&nbsp;number:&nbsp;3309&nbsp;(2021)<\/p>\n\n\n\n<p>Hirofumi Ohashi et al, Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment,&nbsp;<em>iScience<\/em>&nbsp;(2021).&nbsp;<a href=\"http:\/\/dx.doi.org\/10.1016\/j.isci.2021.102367\" target=\"_blank\" rel=\"noreferrer noopener\">DOI: 10.1016\/j.isci.2021.102367<\/a><\/p>\n\n\n\n<p>Daniloski, Z., Jordan, T.X., Wessels, H.-H., Hoagland, D.A., Kasela, S., Legut,<br>M., Maniatis, S., Mimitou, E.P., Lu, L., Geller, E., Danziger, O., Rosenberg, B.R., Phatnani, H., Smibert, P., Lappalainen, T., tenOever, B.R., Sanjana, N.E.,&nbsp;<strong>Identification of required host factors for SARSCoV-2 infection in human cells<\/strong>, Cell (2020),&nbsp;<a href=\"https:\/\/doi.org\/10.1016\/j.cell.2020.10.030\">doi: https:\/\/doi.org\/10.1016\/j.cell.2020.10.030.<\/a><\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition<\/h5>\n\n\n\n<p><a href=\"javascript:;\">Jia Yu<\/a>,&nbsp;<a href=\"javascript:;\">Xuan Yuan<\/a>,&nbsp;<a href=\"javascript:;\">Hang Chen<\/a>,&nbsp;<a href=\"javascript:;\">Shruti Chaturvedi<\/a>,&nbsp;<a href=\"javascript:;\">Evan M. Braunstein<\/a>,&nbsp;<a href=\"javascript:;\">Robert A. Brodsky<\/a><em>Blood<\/em>&nbsp;blood.2020008248.<a rel=\"noreferrer noopener\" href=\"https:\/\/doi.org\/10.1182\/blood.2020008248\" target=\"_blank\">https:\/\/doi.org\/10.1182\/blood.2020008248<\/a><\/p>\n\n\n\n<p>July 24, 2020 Nature<\/p>\n\n\n\n<p><a href=\"https:\/\/www.nature.com\/articles\/s41586-020-2577-1_reference.pdf\">Discovery of SARS-CoV-2 antiviral drugs<br>through large-scale compound repurposing<br>Laura Riva, Shuofeng Yuan, Xin Yin, Laura Martin-Sancho, Naoko Matsunaga, Lars Pache,<br>Sebastian Burgstaller-Muehlbacher, Paul D. De Jesus, Peter Teriete, Mitchell V. Hull,<br>Max W. Chang, Jasper Fuk-Woo Chan, Jianli Cao, Vincent Kwok-Man Poon, Kristina M. Herbert,<br>Kuoyuan Cheng, Tu-Trinh H. Nguyen, Andrey Rubanov, Yuan Pu, Courtney Nguyen,<br>Angela Choi, Raveen Rathnasinghe, Michael Schotsaert, Lisa Miorin, Marion Dejosez,<br>Thomas P. Zwaka, Ko-Yung Sit, Luis Martinez-Sobrido, Wen-Chun Liu, Kris M. White,<br>Mackenzie E. Chapman, Emma K. Lendy, Richard J. Glynne, Randy Albrecht, Eytan Ruppin,<br>Andrew D. Mesecar, Jeffrey R. Johnson, Christopher Benner, Ren Sun, Peter G. Schultz,<br>Andrew I. Su, Adolfo Garc\u00eda-Sastre, Arnab K. Chatterjee, Kwok-Yung Yuen &amp; Sumit K. Chanda<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Treatments Drug repurposing screens identify chemical entities for the development of COVID-19 interventions Malina A. Bakowski,&nbsp; Nathan Beutler,&nbsp; Thomas F. Rogers&nbsp; Nature Communications&nbsp;volume&nbsp;12, Article&nbsp;number:&nbsp;3309&nbsp;(2021) Hirofumi Ohashi et al, Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment,&nbsp;iScience&nbsp;(2021).&nbsp;DOI: 10.1016\/j.isci.2021.102367 Daniloski, Z., Jordan, T.X., Wessels, H.-H., Hoagland, D.A., Kasela, S., Legut,M., Maniatis, S., Mimitou, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":8281,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-8675","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/pages\/8675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/comments?post=8675"}],"version-history":[{"count":0,"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/pages\/8675\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/pages\/8281"}],"wp:attachment":[{"href":"https:\/\/www.telemedical.com\/wordpress\/wp-json\/wp\/v2\/media?parent=8675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}